203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer.
Saved in:
| Title: | 203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer. |
|---|---|
| Authors: | Cazzaniga, M.E.1 (AUTHOR), Martinez Jañez, N.2 (AUTHOR), Kukielka-Budny, B.D.3 (AUTHOR), Ulanska, M.4 (AUTHOR), Bourgeois, H.5 (AUTHOR), Muñoz Mateu, M.6 (AUTHOR), Morales Murillo, S.7 (AUTHOR), Bayo, J.8 (AUTHOR), Cortesi, L.9 (AUTHOR), Pinter, T.10 (AUTHOR), Palacova, M.11 (AUTHOR), Cherciu, N.12 (AUTHOR), Petru, E.13 (AUTHOR), Ettl, J.14 (AUTHOR), De Almeida, C.15 (AUTHOR), Raymond, R.15 (AUTHOR), Villanova, G.R.15 (AUTHOR), Thanh Minh, C. Ta15 (AUTHOR), Rodrigues, A.C.F.16 (AUTHOR), Freyer, G.17 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS447-S447. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
